Revivegen Co., Ltd. (TPEX:7578)
Taiwan · Delayed Price · Currency is TWD 25.50
-0.05 (-0.20%)
Aug 26, 2026, 11:10 AM CST
Revivegen Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 502.49 | 469.23 | 447.86 | 393.59 | 339.16 | 337 | |
Revenue Growth | 13.07% | 4.77% | 13.79% | 16.05% | 0.64% | 71.58% |
Cost of Revenue | 413.17 | 360.06 | 333.73 | 282.94 | 223.14 | 241.52 |
Gross Profit | 89.33 | 109.17 | 114.13 | 110.65 | 116.03 | 95.48 |
Selling, General & Admin | 64.12 | 62.62 | 70.07 | 75.33 | 65.76 | 45.97 |
Research & Development | 3.34 | 3.7 | 7.51 | 4.79 | 4.33 | 2.88 |
Operating Expenses | 58.22 | 66.32 | 77.58 | 80.12 | 70.09 | 48.85 |
Operating Income | 31.11 | 42.84 | 36.55 | 30.53 | 45.94 | 46.64 |
Interest Expense | -8.83 | -12.66 | -35.55 | -5.82 | -5.42 | -3.65 |
Interest & Investment Income | 9.85 | 10.71 | 26.7 | 18.55 | 1.22 | 0.05 |
Earnings From Equity Investments | - | - | - | 0.44 | - | - |
Currency Exchange Gain (Loss) | 4.82 | 4.82 | 32.57 | 2.68 | -2.22 | - |
Other Non Operating Income (Expenses) | -26.77 | -17.35 | -0.7 | 0.55 | 1.49 | 2.36 |
EBT Excluding Unusual Items | 10.18 | 28.38 | 59.58 | 46.93 | 41.01 | 45.4 |
Gain (Loss) on Sale of Investments | - | - | - | 0.88 | - | 0.01 |
Gain (Loss) on Sale of Assets | -9.26 | -9.26 | -6.09 | -0.5 | -2.77 | - |
Other Unusual Items | 0.01 | 0.01 | - | - | - | - |
Pretax Income | 8.05 | 26.25 | 53.48 | 47.31 | 38.24 | 45.41 |
Income Tax Expense | 9.95 | 4.83 | 7.81 | 11.32 | 12.47 | 9.99 |
Earnings From Continuing Operations | -1.9 | 21.42 | 45.68 | 35.99 | 25.77 | 35.42 |
Minority Interest in Earnings | 20.18 | -1.05 | -7.18 | 4.82 | 9.38 | 0.15 |
Net Income | 18.28 | 20.37 | 38.5 | 40.81 | 35.15 | 35.57 |
Net Income to Common | 18.28 | 20.37 | 38.5 | 40.81 | 35.15 | 35.57 |
Net Income Growth | 38.71% | -47.10% | -5.67% | 16.12% | -1.20% | 215.49% |
Shares Outstanding (Basic) | 64 | 59 | 54 | 43 | 30 | 26 |
Shares Outstanding (Diluted) | 65 | 60 | 60 | 49 | 37 | 26 |
Shares Change | 8.16% | -0.25% | 23.26% | 33.56% | 38.70% | 11.24% |
EPS (Basic) | 0.29 | 0.35 | 0.72 | 0.96 | 1.19 | 1.39 |
EPS (Diluted) | 0.28 | 0.34 | 0.64 | 0.84 | 0.96 | 1.35 |
EPS Growth | 25.91% | -46.88% | -23.81% | -12.94% | -28.57% | 185.18% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -895.83 | -1,151 | -1,023 | -1,155 | -557.8 | -8.89 |
Free Cash Flow Per Share | -13.76 | -19.16 | -16.99 | -23.63 | -15.25 | -0.34 |
Dividend Per Share | 0.339 | 0.339 | 0.500 | 0.175 | 0.877 | 0.877 |
Dividend Growth | -32.20% | -32.20% | 185.06% | -80.01% | 0% | 300.00% |
Gross Margin | 17.78% | 23.27% | 25.48% | 28.11% | 34.21% | 28.33% |
Operating Margin | 6.19% | 9.13% | 8.16% | 7.76% | 13.54% | 13.84% |
Profit Margin | 3.64% | 4.34% | 8.60% | 10.37% | 10.36% | 10.55% |
Free Cash Flow Margin | -178.28% | -245.36% | -228.45% | -293.38% | -164.46% | -2.64% |
EBITDA | 144.45 | 137.72 | 114.91 | 100.13 | 118.69 | 102.83 |
EBITDA Margin | 28.75% | 29.35% | 25.66% | 25.44% | 35.00% | 30.51% |
D&A For EBITDA | 113.34 | 94.88 | 78.35 | 69.6 | 72.75 | 56.19 |
EBIT | 31.11 | 42.84 | 36.55 | 30.53 | 45.94 | 46.64 |
EBIT Margin | 6.19% | 9.13% | 8.16% | 7.76% | 13.54% | 13.84% |
Effective Tax Rate | 123.56% | 18.40% | 14.59% | 23.92% | 32.61% | 22.00% |